🎲 The Oddsmaker 25% Downside Club
Ten Stocks Where Expectations Appear Larger Than The Current Business
Investors often focus on what a company could become.
Markets ultimately focus on what a company earns.
The largest stock drawdowns rarely occur because investors identify bad businesses. They occur because investors pay prices that already discount extraordinary future success.
This screen started with a simple requirement:
Wall Street analyst downside of at least 25%.
We then layered in:
Enterprise Value
TEV/Revenue
Operating Cash Flow
Stock-Based Compensation
Cash Conversion Cycle
Recent price momentum
The result is a list of companies where future expectations appear substantially larger than current operating performance.
Top 10 Downside Candidates
Rank | Ticker | Analyst Downside | Risk Score |
|---|---|---|---|
1 | NVTS | -50.6% | 10.0 |
2 | FCEL | -67.0% | 9.8 |
3 | ASTS | -38.2% | 9.7 |
4 | AXTI | -37.7% | 9.5 |
5 | AEHR | -33.0% | 9.4 |
6 | WOLF | -36.8% | 9.2 |
7 | ENPH | -38.1% | 8.8 |
8 | AGL | -29.2% | 8.6 |
9 | MXL | -39.4% | 8.5 |
10 | MRAM | -46.6% | 8.2 |
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $6.4B |
TEV/Revenue | 159x |
Q1 2026 Revenue | $8.6M |
Operating Cash Burn (Q1) | $16.4M |
Cash Balance | $221M |
Navitas generated just $8.6 million of revenue during Q1 2026 while consuming $16.4 million of operating cash. Revenue remains well below prior-year levels despite recent enthusiasm surrounding AI power infrastructure.
Valuation Math
At an 8x sales multiple:
Required Revenue = $800M
Current Annualized Revenue = ~$34M
Revenue Expansion Required = ~24x
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -75% | 50% |
Base | -50% | 35% |
Bull | +50% | 15% |
2. FuelCell Energy (FCEL)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $1.2B |
Analyst Downside | -67% |
Operating Cash Flow | -$114M |
Cash Conversion Cycle | 357 Days |
Unlike most companies on this list, FuelCell's challenge is not primarily valuation.
It is economics.
Annual cash consumption represents nearly 10% of enterprise value.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -80% | 55% |
Base | -60% | 35% |
Bull | +40% | 10% |
3. AST SpaceMobile (ASTS)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | ~$40B |
Analyst Downside | -38% |
Q1 Revenue | $14.7M |
Q1 Net Loss | $191M |
Revenue Guidance | $150M-$200M |
AST generated $14.7 million of Q1 revenue while reporting a $191 million quarterly loss. Revenue missed analyst expectations by a substantial margin.
Recent launch delays and satellite deployment setbacks have increased execution risk while maintaining a valuation that assumes large-scale commercial adoption.
Valuation Math
At 10x revenue:
Required Revenue = $4.0B
Management's 2026 revenue guidance:
$150M-$200M
The valuation implies revenue eventually exceeding current guidance by roughly 20x.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -70% | |
40% | ||
Base | -35% | 40% |
Bull | +150% | 20% |
4. AXT (AXTI)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $7.4B |
TEV/Revenue | 77x |
Analyst Downside | -37.7% |
Cash Conversion Cycle | 459 Days |
Valuation Math
At 8x sales:
Required Revenue = $925M
The market currently values AXT as though it will become dramatically larger than its current operating footprint.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -70% | 45% |
Base | -40% | 35% |
Bull | +80% | 20% |
5. Aehr Test Systems (AEHR)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $3.1B |
TEV/Revenue | 69x |
Analyst Downside | -33% |
Cash Conversion Cycle | 616 Days |
Valuation Math
At 10x sales:
Required Revenue = $312M
Investors are effectively pricing years of continued silicon carbide demand growth.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -65% | 40% |
Base | -35% | 40% |
Bull | +60% | 20% |
The Most Important Observation
The common characteristic across this list is not poor technology.
Most of these companies operate in attractive industries:
AI Infrastructure
Satellite Communications
Hydrogen
Silicon Carbide
Power Electronics
The common characteristic is valuation.
Many trade at enterprise values that imply revenue growth of 10x–25x before investors earn an attractive return.
History suggests that when expectations become this elevated, future stock performance becomes increasingly dependent on flawless execution.
The Oddsmaker takeaway is simple:
The higher the expectations, the smaller the margin for error.
And in investing, margin for error is often the most important metric of all.
6. Wolfspeed (WOLF)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $3.8B |
TEV/Revenue | 5.4x |
Analyst Downside | -36.8% |
Operating Cash Flow | -$391M |
Cash Conversion Cycle | 189 Days |
1-Month Return | +152% |
What Matters
Unlike NVTS or AEHR, Wolfspeed's problem is not revenue multiple expansion.
The problem is capital intensity.
The company has spent billions building silicon carbide manufacturing capacity while demand growth has fallen short of prior expectations.
Valuation Math
Current valuation assumes:
Silicon carbide EV adoption accelerates
Capacity utilization improves materially
Significant margin expansion
Capital requirements moderate
The challenge is that negative operating cash flow remains extremely large relative to enterprise value.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -70% | 45% |
Base | -40% | 35% |
Bull | +100% | 20% |
7. Enphase Energy (ENPH)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $8.8B |
TEV/Revenue | 6.3x |
Analyst Downside | -38.1% |
Operating Cash Flow | $191M |
Stock-Based Compensation | $207M |
Cash Conversion Cycle | 139 Days |
What Matters
Enphase is one of the few names on this list generating meaningful operating cash flow.
This is not a business quality short thesis.
This is a valuation and demand normalization thesis.
Valuation Math
The company currently trades closer to historical peak multiples despite:
slower residential solar demand
elevated interest rates
softer installation activity
The market continues to assume a return to prior growth rates.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -50% | 35% |
Base | -25% | 45% |
Bull | +50% | 20% |
8. agilon health (AGL)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $1.3B |
TEV/Revenue | 0.23x |
Analyst Downside | -29.2% |
Operating Cash Flow | -$50M |
Stock-Based Compensation | $39M |
1-Month Return | +224% |
What Matters
This is one of the most interesting stocks on the screen.
Unlike most names on this list, valuation appears inexpensive.
However, investors are paying for a turnaround.
Valuation Math
The key question is not revenue.
The key question is profitability.
The market is assuming:
improved physician economics
lower medical cost trends
margin stabilization
Failure to execute could lead to renewed pressure despite the low revenue multiple.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -60% | 40% |
Base | -30% | 40% |
Bull | +30% | 20% |
9. MaxLinear (MXL)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $8.8B |
TEV/Revenue | 17.4x |
Analyst Downside | -39.4% |
Operating Cash Flow | $22M |
Stock-Based Compensation | $74M |
1-Month Return | +88% |
What Matters
MaxLinear screens as expensive relative to current semiconductor fundamentals.
Revenue growth remains muted while valuation has expanded significantly.
Valuation Math
At 8x revenue:
Required Revenue = ~$1.1B
Current valuation implies substantial future growth despite limited current operating momentum.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -50% | 35% |
Base | -30% | 45% |
Bull | +40% | 20% |
10. Everspin Technologies (MRAM)
The Numbers
Metric | Value |
|---|---|
Enterprise Value | $696M |
TEV/Revenue | 12.2x |
Analyst Downside | -46.6% |
Operating Cash Flow | $9M |
Stock-Based Compensation | $5.5M |
Cash Conversion Cycle | 146 Days |
What Matters
MRAM is arguably the highest-quality business among the names on this screen.
The company:
generates cash flow
has a differentiated memory technology
maintains a stronger balance sheet
The downside argument is primarily valuation-driven.
Valuation Math
The market is discounting:
rapid adoption of MRAM technology
substantial future design wins
continued market share gains
Any slowdown in adoption could compress the multiple significantly.
Odds
Scenario | Price Outcome | Probability |
|---|---|---|
Bear | -50% | 35% |
Base | -25% | 45% |
Bull | +60% | 20% |
Oddsmaker Summary Table
Ticker | TEV/Revenue | Analyst Downside | OCF ($M) | Risk Score |
|---|---|---|---|---|
NVTS | 159x | -50.6% | -46 | 10.0 |
AXTI | 77x | -37.7% | N/A | 9.5 |
AEHR | 69x | -33.0% | -7 | 9.4 |
MXL | 17x | -39.4% | 22 | 8.5 |
MRAM | 12x | -46.6% | 9 | 8.2 |
ASTS | NM | -38.2% | -91 | 9.7 |
FCEL | 7x | -67.0% | -114 | 9.8 |
ENPH | 6x | -38.1% | 191 | 8.8 |
WOLF | 5x | -36.8% | -391 | 9.2 |
AGL | 0.2x | -29.2% | -50 | 8.6 |
Highest Conviction Ideas
Tier 1 (Best Risk/Reward)
NVTS
ASTS
FCEL
AEHR
WOLF
These five names combine:
Significant analyst downside
Weak cash flow profiles
Elevated expectations
Valuation assumptions that require extraordinary future execution
The common thread is not bad technology.
The common thread is that current enterprise values appear to discount outcomes that are materially larger than today's operating businesses.